If you made any changes in Pure these will be visible here soon.

Personal profile


Jasmin Grigg is a Research Fellow with the Eastern Health Clinical School, Monash University and Turning Point, Eastern Health. She has a research background in mental health and public health, with an emerging track record in addictions treatment.

Jasmin is experienced in clinical trials and public health program evaluation. She has managed six large clinical trials to improve addiction and mental health outcomes across patient and community populations, including Turning Point’s current NHMRC-funded nationwide R2C trial for alcohol use disorder. She has led the evaluation of eight state-level and national public health programs, including 1800 ICE ADVICE for individuals and families affected by methamphetamine use, the alcohol and drug helpline DirectLine, and The Drug and Alcohol Clinical Advisory Service for health professionals.

Jasmin has also undertaken a range of translational work. In 2018, she was commissioned by the Victorian Department of Health and Human Services (DHHS) to lead the development of the Methamphetamine Treatment Guidelines, a key resource for Victorian health professionals in the clinical management of methamphetamine use disorder. In her role at Turning Point, Jasmin has been involved in a range of projects funded by the DHHS to inform alcohol and drug policy and practice change. In her previous role at the Monash Alfred Psychiatry Research Centre, she developed training tools for health professionals to improve response to family violence in the community, including ‘When She Talks to You about the Violence: A Toolkit for Health Practitioners in Victoria’ (2014). She also contributed to policy reform to improve the safety of women with severe mental illness, and developed sex-specific algorithms to assist clinical decision-making with the goal of balancing effective psychiatric treatment while minimising the endocrine adverse effects of antipsychotic drugs.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2017 2021

Research Output 2014 2019

A structured telephone-delivered intervention to reduce problem alcohol use (Ready2Change): Study protocol for a parallel group randomised controlled trial

Lubman, D. I., Grigg, J., Manning, V., Hall, K., Volpe, I., Dias, S., Baker, A., Staiger, P. K., Reynolds, J., Harris, A., Tyler, J. & Best, D., 19 Aug 2019, In : Trials. 20, 1, 12 p., 515.

Research output: Contribution to journalArticleOtherpeer-review

Open Access
1 Citation (Scopus)

Synthetic cannabinoid use disorder: an update for general psychiatrists

Grigg, J., Manning, V., Arunogiri, S. & Lubman, D. I., 1 Jun 2019, In : Australasian Psychiatry. 27, 3, p. 279–283 5 p.

Research output: Contribution to journalArticleResearchpeer-review

8 Citations (Scopus)

Adjunctive raloxifene for postmenopausal women with schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials

Zhu, X. M., Zheng, W., Li, X. H., Cai, D. B., Yang, X. H., Ungvari, G. S., Ng, C. H., Wang, X. P., Kulkarni, J., Grigg, J., Ning, Y. P. & Xiang, Y. T., 1 Jul 2018, In : Schizophrenia Research. 197, p. 288-293 6 p.

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Borderline personality disorder and polycystic ovary syndrome: A review of the literature

Tan, R. Y. M., Grigg, J. & Kulkarni, J., 1 Feb 2018, In : Australian & New Zealand Journal of Psychiatry. 52, 2, p. 117-128 12 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

3 Citations (Scopus)

Effect of the Glutamate NMDA Receptor Antagonist Memantine as Adjunctive Treatment in Borderline Personality Disorder: An Exploratory, Randomised, Double-Blind, Placebo-Controlled Trial

Kulkarni, J., Thomas, N., Hudaib, A. R., Gavrilidis, E., Grigg, J., Tan, R., Cheng, J., Arnold, A. & Gurvich, C., 1 Feb 2018, In : CNS Drugs. 32, 2, p. 179-187 9 p.

Research output: Contribution to journalArticleResearchpeer-review